Respiratory syncytial virus bronchiolitis: prevention and treatment
- 8 September 2008
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Opinion on Pharmacotherapy
- Vol. 9 (14), 2451-2458
- https://doi.org/10.1517/14656566.9.14.2451
Abstract
Acute respiratory illness due to respiratory syncytial virus is one of the most common causes of hospitalization in very young children worldwide. The virus was discovered half a century ago, yet the underlying mechanisms of the disease are not fully understood and treatment remains supportive. This review article discusses therapeutic and preventive strategies, past, present and future, in the battle against respiratory syncytial virus. Prevention of severe respiratory syncytial virus infection in high-risk children can be achieved by the administration of specific monoclonal antibodies. Current issues include the management of respiratory syncytial virus infection in those with underlying immunological disease, the prevention of long-term airway morbidity and the development of innovative vaccines.Keywords
This publication has 68 references indexed in Scilit:
- Respiratory Syncytial Virus Infection in Patients with Hematological Diseases: Single-Center Study and Review of the LiteratureClinical Infectious Diseases, 2008
- Motavizumab, A Neutralizing Anti-Respiratory Syncytial Virus (Rsv) Monoclonal Antibody Significantly Modifies The Local And Systemic Cytokine Responses Induced By Rsv In The Mouse ModelVirology Journal, 2007
- Randomized Controlled Multicenter Trial of Aerosolized Ribavirin for Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic Cell Transplant RecipientsClinical Infectious Diseases, 2007
- Antiviral Immune Responses and Lung Inflammation after Respiratory Syncytial Virus InfectionProceedings of the American Thoracic Society, 2005
- The future of respiratory syncytial virus vaccine developmentThe Pediatric Infectious Disease Journal, 2004
- Differences in management of bronchiolitis between hospitals in The NetherlandsEuropean Journal of Pediatrics, 2000
- Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failureThe Journal of Pediatrics, 1996
- Albuterol responsiveness in infants with respiratory failure caused by respiratory syncytial virus infectionThe Journal of Pediatrics, 1995
- Early ribavirin treatment of respiratory syncytial viral infection in high-risk childrenThe Journal of Pediatrics, 1990
- Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral InfectionNew England Journal of Medicine, 1983